MIT Launches Interdisciplinary Cancer Center


By Allison Proffitt

March 6, 2008 | Although the official groundbreaking isn't until tomorrow, the David H. Koch Institute for Integrative Cancer Research at MIT (Massachusetts Institute of Technology) opened today in Cambridge.

The Koch Institute will replace the previous MIT Center for Cancer Research, an NCI-designated basic research center since 1974. The institute brings together cancer scientists and cancer engineers, said Tyler Jacks, David H. Koch Professor of Biology, and founding director of the Koch Institute.

Jacks and colleagues met today at the Broad Institute, opposite the site of the future building, to discuss the future of cancer research at MIT and the goals for the Koch Institute.

The institute will be "explicitly interdisciplinary," said Jacks, listing researchers from the systems biology, nanotechnology, engineering, materials science, and biology fields that will be housed in or affiliated with the new facility. Jacks plans for the institute to combine science and engineering to offer "new innovative approaches at the interface of these disciplines."

Physically, the building has been designed to encourage interaction. With space to house 25 laboratories, each floor will include both biological and engineering lab space. In the center of the building, offices and common areas will be designed to bring scientists and engineers together. The core facilities will also be located in the center of the building. Jacks said that the institute plans to include a biotechnology center with high-throughput sequencing facilities.

"We've placed our chips with Solexa, which is now owned by Illumina," said Jacks of the institute's preferred sequencing platform. However, he acknowledged that with the rate the technology is advancing, that could change. "We'll be constantly evaluating [new] technologies, because they're critical," said David Houseman, the Ludwig Professor of Biology and a Koch Institute member.

Jacks hopes the building will be completed by December 2010, but emphasized that the Institute is already in existence. "The institute came into being today," he said. "We're not waiting for the building to open. We're a cohesive faculty."

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

This Bio•IT World Briefing On “Next-Generation Sequencing,” underwritten by GenomeQuest, Inc.,
presents a selection of feature stories, interviews,commentaries, conference reports, and editorials on the emergence, opportunities, and challenges posed by high-throughput sequencing. Covered in this collection: the launch of new platforms from Applied Biosystems and Helicos; new applications of nextgen sequencing; the rise of personal genomics; and informatics solutions to vexing problem of managing the vast volumes of next-gen data. Download now



SGI's Meeting Today’s Computational Needs for Science

The quest to better understand disease mechanisms and find new treatments is driven by new laboratory technologies and ever-more sophisticated modeling and simulation efforts. As such, life sciences R&D investigations increasingly are relying on more powerful computing resources. The challenge is how to accommodate the broad mix of applications.

Addressing this issue, this paper produced by the Bio-IT World Custom Publishing Group discusses a new SGI Hybrid Computing Environment approach. It optimally uses shared memory systems, multi-processor clusters, and FPGAs to accelerate computational workflows.



sgi_protm

SGI's Supercharging Proteomics Discovery

The deeper study of proteins and their interactions can reveal scientific information once considered nearly untouchable to scientists and researchers. Today, unprecedented advancements in computing power are enabling the creation of mounds of proteomic based data along with the accompanying bottlenecks data can create.

Rather than just “simplify the experiment” to fit the computational resources an alternative is now available with the SGI Proteomics Appliance. This complimentary white paper, produced by the Bio-IT World Custom Publishing Group, looks at ways to use the Proteomic Appliance to handle the most intensive proteomics computing tasks facing science today.



Life Science Webcasts & Podcasts

Trade Commission of Spain

Spain’s Emerging Biotech Revolution

The biotechnology sector is growing 10 percent faster in Spain than it is in the U.S. Driven by a culture, government and private sector that are open-minded and optimistic, Spain-based companies are emerging as leaders in this dynamic field. Discover how your business can capitalize on creative solutions from Spain-based enterprises by learning about:

  • Trends and factors driving the growth of Spain’s biotechnology sector.
  • The Spanish government’s aggressive policies and incentive programs for biotechnology research.
  • Biotechnology spin-offs, bio-clusters and new research centers in Spain that are combining entrepreneurial spirit with larger-than-ever resources.
  • The strength of Spain’s biomedicine community, and how U.S. pharmaceutical companies are capitalizing on it.

Download Now


More Podcasts

Job Openings

Friedrich Miescher Institute for Biomedical Research - Part of the Novartis Research Foundation
Basel, Switzerland is looking for a Head of IT Systems & Infrastructure. You will manage a cutting-edge core server and network infrastructure, comprising Linux and Solaris, as well as a robust Windows and Macintosh environment. We look forward to receiving your application: [email protected]. click for more information

Lilly Singapore Center for Drug Discovery (LSCDD) - Associate Director of Informatics
Lead and mentor a strong team for the Bioinformatics group at the Integrative Computational Sciences (ICS) department at LSCDD towards the development of novel algorithms, data analysis methods and software tools for drug discovery. Work closely with the Software Engineering group at ICS, and collaborate with the Discovery IT organization in Europe and USA. For additional information, or to apply visit: LSCDD

Related Resources & Products

Cancer Immunotherapies and Vaccines: Pipeline Analysis and Competitive Dynamics
Cancer Immunotherapies and Vaccines: Pipeline Analysis and Competitive Dynamics
Advances in Cancer Vaccines
Cancer Molecular Markers
Cancer Molecular Markers




For reprints and/or copyright permission, please contact RMS, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext 100 or via email to [email protected].